A 38‑year‑old mother of four wakes at 3 a.m. with searing flank pain and walks into an ER expecting a kidney stone. Weeks later, she learns it is stage IV cholangiocarcinoma—bile duct cancer that has spread to her spine. This is Tiffany’s story of tests, surgery, chemo and immunotherapy, the mental health whiplash, and the fierce advocacy it takes to keep moving through uncertainty. October is Liver Cancer Awareness Month, a reminder to know the signs and advocate for early detection.

Over 40% of cancer survivors in the U.S. experience financial toxicity — the heavy burden of medical and non-medical costs that come with treatment. This blog explains what financial toxicity really means, why it’s not your fault, and where patients and caregivers can find trusted help.

A new study from the University of Florida and MD Anderson Cancer Center reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy lived significantly longer. This discovery could open the door to future “universal” cancer vaccines that enhance immune responses.

Chemotherapy doesn’t always bring the results patients and caregivers hope for. This blog explores why some breast cancer tumours resist chemo, how genetic and biological factors play a role, and what steps patients and caregivers can take to ensure treatment is tailored and effective.

A new study suggests that some chemotherapy drugs, especially docetaxel, may change the brain’s lymphatic drainage system and play a role in “chemo brain.” Researchers found that these changes could affect how the brain clears waste and maintains healthy function.

HuMOLYTE is inviting individuals preparing for chemotherapy to participate in a Patient Experience Survey. Selected participants will receive a complimentary supply of HuMOLYTE, a GRAS medical food designed to support hydration, electrolyte balance, and mucosal health. Participation includes following the recommended protocol and completing a short post-treatment survey. Spots are limited—apply today.

Colorectal cancer rates are four times higher in people born in 1990 compared to those born in 1950. And it’s not just colorectal cancer—14 types of cancer are rising in people under 50. This blog breaks down why this is happening, what it means for you or your loved one, and how to take action today.

At 31, Christine felt a hard, unmoving lump and heard the words “This isn’t benign.” Her story moves from panic to a plan—fertility decisions, reframing chemo as medicine, choosing lumpectomy after a strong response, and facing the unexpected weight of survivorship. For Breast Cancer Awareness Month, she shares what truly helped—and what patients and caregivers can do next.

Extra nodal extension (ENE) happens when cancer cells break through the covering of a lymph node. While it doesn’t change your cancer stage, it can influence treatment decisions. Learn what ENE means and how it may affect care.

October shines a light on breast cancer, metastatic breast cancer, and liver cancer. For patients and caregivers, it’s a time to focus on early detection, support, and advocacy.

A new study has found that certain bacteria and fungi in the mouth may be linked to a higher chance of developing pancreatic cancer. Researchers discovered that people with certain oral microbes were more likely to develop the disease, suggesting that a simple mouth swab could one day help with earlier detection. While this research is still in its early stages, it offers hope for new screening tools and reminds us of the importance of everyday oral health.

When Lonnie was diagnosed with stage four metastatic prostate cancer at 54, he faced fear, pain, and overwhelming decisions. Seven years later, he shares what kept him moving forward: slowing down, learning, and caring for his mental health. His message is especially powerful this September, during Prostate Cancer Awareness Month.

GLP-1 agonists, widely prescribed for diabetes and weight loss, do not appear to increase breast cancer risk according to large studies. In fact, by supporting weight loss and better diabetes control, they may even help improve outcomes for breast cancer patients.

IGH Naturals has announced the start of patient enrollment in a clinical trial evaluating Humolyte®, a novel oral solution designed to ease chemotherapy-related side effects such as diarrhea, vomiting, and painful mouth sores. Conducted at multiple clinical sites in India, the approved study will assess Humolyte’s potential to improve hydration, reduce the severity of oral mucositis, and lessen the need for IV fluids—ultimately aiming to enhance comfort and quality of life for cancer patients.

Loss of libido is a common yet rarely discussed side effect of breast cancer treatment. Up to 80% of patients experience changes in sexual desire, intimacy, or comfort. This article explores why it happens, how to talk about it with your partner and doctor, and what resources can help you reclaim intimacy on your terms.

HuMOLYTE, a hydration solution designed for chemotherapy patients, won first place at Pitch Elk Grove 2025. More than a business win, this milestone highlights new hope for patients and caregivers managing the side effects of cancer treatment.

Young adults caring for a parent with cancer face unique emotional, financial, and social challenges. Recognizing overwhelming emotions, prioritizing self-care, and seeking supportive resources can transform caregiving into a journey of growth, resilience, and purpose.

A Michigan State University team has engineered a temperature-responsive, shampoo-like hydrogel designed to briefly narrow tiny scalp blood vessels so less chemotherapy reaches hair follicles. Early animal data suggest the approach may help preserve hair, but human trials have not yet begun.

September is one of the most powerful months for cancer awareness, honoring childhood, ovarian, prostate, thyroid, blood, and gynecologic cancers. Each ribbon tells a story, each campaign sparks conversation, and together they create a movement for education, early detection, and support.

When Alli Macken was diagnosed with stage 4 appendix cancer, she feared the worst. Nine years, multiple surgeries, and countless treatments later, she’s here to remind others: stage 4 is not a death sentence. This August, during Appendix Cancer Awareness Month, her story is a beacon of hope.